Ilias Goranitis

2.2k total citations
75 papers, 915 citations indexed

About

Ilias Goranitis is a scholar working on Genetics, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Ilias Goranitis has authored 75 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 28 papers in Economics and Econometrics and 11 papers in General Health Professions. Recurrent topics in Ilias Goranitis's work include Genomics and Rare Diseases (27 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers) and Economic and Environmental Valuation (8 papers). Ilias Goranitis is often cited by papers focused on Genomics and Rare Diseases (27 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers) and Economic and Environmental Valuation (8 papers). Ilias Goranitis collaborates with scholars based in Australia, United Kingdom and Canada. Ilias Goranitis's co-authors include Zornitza Stark, Lycourgos Liaropoulos, Stephanie Best, Hareth Al‐Janabi, John Christodoulou, Joanna Coast, Tiffany Boughtwood, You Wu, Melissa Martyn and Andrew J. Mallett and has published in prestigious journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Ilias Goranitis

69 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilias Goranitis Australia 19 312 263 188 113 74 75 915
Георги Искров Bulgaria 17 204 0.7× 312 1.2× 71 0.4× 108 1.0× 98 1.3× 64 778
Ridgely Fisk Green United States 14 417 1.3× 52 0.2× 90 0.5× 195 1.7× 99 1.3× 23 865
Amy Nisselle Australia 16 479 1.5× 55 0.2× 76 0.4× 143 1.3× 106 1.4× 49 1.3k
E. Jolly Canada 14 221 0.7× 165 0.6× 579 3.1× 104 0.9× 67 0.9× 25 1.2k
Alexander Hamilton United Kingdom 14 143 0.5× 59 0.2× 77 0.4× 121 1.1× 187 2.5× 62 846
Thomas Morel Belgium 11 81 0.3× 249 0.9× 55 0.3× 63 0.6× 50 0.7× 32 634
Beth A. Pletcher United States 19 561 1.8× 70 0.3× 136 0.7× 253 2.2× 296 4.0× 51 1.3k
Nathalie McIntosh United States 15 112 0.4× 81 0.3× 156 0.8× 130 1.2× 326 4.4× 42 894
Debra Lochner Doyle United States 11 287 0.9× 38 0.1× 99 0.5× 202 1.8× 80 1.1× 18 835
Jessica Bytautas Canada 19 282 0.9× 68 0.3× 148 0.8× 234 2.1× 39 0.5× 41 811

Countries citing papers authored by Ilias Goranitis

Since Specialization
Citations

This map shows the geographic impact of Ilias Goranitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilias Goranitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilias Goranitis more than expected).

Fields of papers citing papers by Ilias Goranitis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilias Goranitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilias Goranitis. The network helps show where Ilias Goranitis may publish in the future.

Co-authorship network of co-authors of Ilias Goranitis

This figure shows the co-authorship network connecting the top 25 collaborators of Ilias Goranitis. A scholar is included among the top collaborators of Ilias Goranitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilias Goranitis. Ilias Goranitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goranitis, Ilias, et al.. (2026). Gauging Patient- and Family-Perceived Value of Genetic Testing for Atrial Fibrillation. Heart Lung and Circulation. 35(3). e29–e31.
2.
McGahan, Eugene, Tatiane Yanes, Jennifer Berkman, et al.. (2025). Utility of Germline, Somatic and ctDNA Testing in Adults With Cancer. Cancer Medicine. 14(15). e71080–e71080.
3.
Harris, Madeleine, et al.. (2025). The value of functional genomics: a contingent valuation. Expert Review of Pharmacoeconomics & Outcomes Research. 26(2). 195–202.
4.
Lynch, Fiona, Stephanie Best, Clara Gaff, et al.. (2024). Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation. International Journal of Neonatal Screening. 10(1). 6–6. 17 indexed citations
5.
Goranitis, Ilias, et al.. (2024). Determining priority indicators of utility for genomic testing in rare disease: A Delphi study. Genetics in Medicine. 26(6). 101116–101116. 5 indexed citations
6.
Best, Stephanie, C. Richards, Michael C. Quinn, et al.. (2024). Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services. European Journal of Human Genetics. 32(11). 1428–1435. 2 indexed citations
7.
Marshall, Deborah A., James Buchanan, Kurt D. Christensen, et al.. (2024). Paving the path for implementation of clinical genomic sequencing globally: Are we ready?. Health Affairs Scholar. 2(5). qxae053–qxae053. 5 indexed citations
8.
Ride, Jemimah, et al.. (2024). A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist. PharmacoEconomics. 42(10). 1161–1175. 18 indexed citations
9.
Mordaunt, Dylan, Sebastian Lunke, Stefanie Eggers, et al.. (2023). The cost of proband and trio exome and genome analysis in rare disease: A micro-costing study. Genetics in Medicine. 26(4). 101058–101058. 7 indexed citations
10.
Lynch, Fiona, Stephanie Best, Ilias Goranitis, et al.. (2023). Australian public perspectives on genomic data governance: responsibility, regulation, and logistical considerations. European Journal of Human Genetics. 32(3). 295–301. 3 indexed citations
11.
Robertson, Eden G., Lauren Kelada, Stephanie Best, et al.. (2023). Quality of life in caregivers of a child with a developmental and epileptic encephalopathy. Developmental Medicine & Child Neurology. 66(2). 206–215. 9 indexed citations
12.
Robertson, Eden G., N Roberts, Rebecca Macintosh, et al.. (2023). “Somewhere to turn to with my questions”: A pre-post pilot of an information linker service for caregivers who have a child with a Developmental and Epileptic Encephalopathy. European Journal of Paediatric Neurology. 47. 94–104. 5 indexed citations
13.
Mordaunt, Dylan, Kim Dalziel, Ilias Goranitis, & Zornitza Stark. (2023). Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia. European Journal of Human Genetics. 31(9). 977–979. 16 indexed citations
14.
Mordaunt, Dylan, et al.. (2023). Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia. BMJ Open. 13(11). e069441–e069441. 2 indexed citations
15.
Jayasinghe, Kushani, You Wu, Zornitza Stark, et al.. (2021). Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases. Kidney International Reports. 6(11). 2850–2861. 27 indexed citations
16.
Akesson, Lauren, Adam Bournazos, Andrew Fennell, et al.. (2020). Rapid exome sequencing and adjunct RNA studies confirm the pathogenicity of a novel homozygous ASNS splicing variant in a critically ill neonate. Human Mutation. 41(11). 1884–1891. 8 indexed citations
17.
Best, Stephanie, Zornitza Stark, Peta Phillips, et al.. (2020). Clinical genomic testing: what matters to key stakeholders?. European Journal of Human Genetics. 28(7). 866–873. 26 indexed citations
18.
Downie, Lilian, David J. Amor, Jane Halliday, et al.. (2020). Exome Sequencing for Isolated Congenital Hearing Loss: A Cost‐Effectiveness Analysis. The Laryngoscope. 131(7). E2371–E2377. 10 indexed citations
19.
Tan, Tiong Yang, Sebastian Lunke, Belinda Chong, et al.. (2019). A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis. European Journal of Human Genetics. 27(12). 1791–1799. 35 indexed citations
20.
Jayasinghe, Kushani, Zornitza Stark, Chirag Patel, et al.. (2019). Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol. BMJ Open. 9(8). e029541–e029541. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Георги Искров Breakdown of academic impact, for papers by Ridgely Fisk Green Breakdown of academic impact, for papers by Amy Nisselle Breakdown of academic impact, for papers by E. Jolly Breakdown of academic impact, for papers by Alexander Hamilton Breakdown of academic impact, for papers by Thomas Morel Breakdown of academic impact, for papers by Beth A. Pletcher Breakdown of academic impact, for papers by Nathalie McIntosh Breakdown of academic impact, for papers by Debra Lochner Doyle Breakdown of academic impact, for papers by Jessica Bytautas
Rankless by CCL
2026